1. About Quro Pipeline Organization News ContactHome Site Map INNOVATION IN INFECTIOUS DISEASES TREATMENT

2. About Quro Pipeline Organization News ContactHome Site Map Quro Science Inc. Quro is a spin-off biotechnology company from Institut Pasteur Korea (IP-K) committed to develop novel therapeutics against infectious diseases. Quro’s main focus is on human immunodeficiency virus (HIV), hepatitis C virus (HCV) and tuberculosis (TB) infection. Quro has exclusive rights to develop and commercialize drug candidates discovered with IP-K’s proprietary state-of-the-art technologies including the PhenomicScreen TM and PhenomicID TM platforms. Quro has in-house expertise in preclinical and clinical development management and operates as a virtual company using contract research organizations (CROs) for execution of the development works. Quro intends to license out the products in the course of the clinical development to larger partners for further development.

3. About Quro Pipeline Organization News ContactHome Site Map Quro’s Operations Model

4. About Quro Pipeline Organization News ContactHome Site Map

5. About Quro Pipeline Organization News ContactHome Site Map

6. About Quro Pipeline Organization News ContactHome Site Map Organizational Chart

7. About Quro Pipeline Organization News ContactHome Site Map Management Team Dr. Ulf Nehrbass, CEO Dr. Nehrbass graduated in Biochemistry from Cambridge University, UK, and obtained his Ph.D. at the EMBL in Heidelberg, Germany in 1992. After a postdoctoral position in the Howard Hughes Medical Institute at the Rockefeller University, New York, he joined the Institut Pasteur in Paris, in 1998 where he was Head of the Nuclear Cell Biology unit and CNRS Research Director. After a number of research awards he was elected member of EMBO in 2005. He has been CEO of IP-Korea since its inception in 2004.

8. About Quro Pipeline Organization News ContactHome Site Map Board of Directors Dr. Ulf Nehrbass Head of the Nuclear Cell Biology unit, Institut Pasteur in Paris CNRS Research Director CEO of Institut Pasteur Korea Dr. Yung Bog Chae Chairman of Institut Pasteur Korea Board of Directors Chairman of Gyeonggi Bio-Center Former Minister, Ministry of Science and Technology, Republic of Korea Mr. Seok Won Yoon General Manager, Hanwha Venture Capital Corp. Director, Green & Biotech, Inc. General Manager, Basic Venture Capital, Co., Ltd

9. About Quro Pipeline Organization News ContactHome Site Map Board of Directors Dr. Yongmo Lee Director, Center for International Cooperation, National Research Foundation Associate Professor, Dr. Myung Whan Park Director of Gyeonggi Bio-Center Dr. Jae Whan Park Professor, Department of Business and Management School Of Social Science, Chung-Ang University External Auditor

10. About Quro Pipeline Organization News ContactHome Site Map Bulletin board here

11. About Quro Pipeline Organization News ContactHome Site Map Quro Science Inc. Sampyeong-dong 696 Bundang-gu Seongnam-si Gyeonggi-do, Korea Tel: +82-31-8018-8370 Fax: +82-31-8018-8380 info@quroscience.com Quro Science Inc. Sampyeong-dong 696 Bundang-gu Seongnam-si Gyeonggi-do, Korea Tel: +82-31-8018-8370 Fax: +82-31-8018-8380 info@quroscience.com